论文信息 - A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivation. - 字舞流文

A short washout period from fingolimod to anti-CD20 therapy is safe and decreases the risk of reactivation.

C. Louapre | E. Maillart | C. Papeix | T. Roux | S. Gassama | M. Boudot de la Motte | F. Lejeune | A. Garmendia